Core Viewpoint - The company is in the process of issuing shares and paying cash to acquire 100% of Hangzhou Lipo Technology Co., Ltd. and is also raising supporting funds, with the transaction subject to various approvals and conditions [1][2][3]. Transaction Overview - The transaction consists of two parts: issuing shares and paying cash for asset acquisition, and raising supporting funds. The successful implementation of both is interdependent, meaning if one fails, the other will not proceed [2][5]. - The valuation and pricing of the transaction have not yet been determined, and it is expected to constitute a major asset restructuring as per relevant regulations [2][4]. - The funding subscribers for the supporting funds are companies controlled by the actual controller of the company, indicating that this transaction is a related party transaction [2][4]. Progress of the Transaction - The company's stock was suspended from trading starting February 24, 2025, with an expected suspension period of no more than 10 trading days [3]. - The company has been actively disclosing updates regarding the transaction, with several announcements made on April 8, May 8, and June 7, 2025, indicating that due diligence, auditing, and evaluation processes are ongoing [4][5]. - The company will continue to fulfill its information disclosure obligations in accordance with legal requirements as the transaction progresses [4][5].

证券代码：600539 证券简称：狮头股份 公告编号：临 2025-039 狮头科技发展股份有限公司 关于发行股份及支付现金购买资产并募集配套资金 暨关联交易事项的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次交易标的资产的审计、评估工作尚未完成，交易价格尚未确定。本 次交易方案尚需经公司董事会及股东大会批准、上交所审核、中国证监会同意注 册及相关法律法规所要求的其他可能涉及的批准或核准（如需）。上述批准、审 核通过和同意注册均为本次交易的前提条件。本次交易能否取得上述批准、审核 通过或同意注册，以及最终取得的时间均存在不确定性。 本次交易方案由发行股份及支付现金购买资产和募集配套资金两部分组 成。本次发行股份及支付现金购买资产与募集配套资金的成功实施互为前提，其 中任何一项未获得所需的批准或其他原因导致无法付诸实施，则前述两项均不实 施。截至本公告日，募集配套资金认购方尚未提供资金证明等相关材料，若未来 募集配套资金认购方未能及时、足额认缴配套融资，或因其他原因导致本次募集 配套资金未能成 ...

证券代码：600539 证券简称：狮头股份 公告编号：临 2025-038 狮头科技发展股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 公司拟为杭州创化与福建片仔癀化妆品股份有限公司（"片仔癀"）签订的 2025 年度片仔癀化妆品经销合同书所约定的账期以自有房产提供抵押担保，担保最高额 度为 800 万元。抵押物为公司名下位于山西省太原市滨河西路 51 号 3 幢 1-2 层 0201 号非住宅房地产（不动产权证号为：晋（2024）太原市不动产权第 0010929 号）， 截至评估基准日 2024 年 12 月 31 日，上述房产市场价值经市场法评估，评估价值 （二）担保事项履行的内部决策程序 公司于 2025 年 6 月 17 日召开第九届董事会第二十一次会议，审议通过了《关 于为控股子公司提供抵押担保的议案》，同意公司为杭州创化与片仔癀签订的 2025 年度片仔癀化妆品经销合同书所约定的账期以自有房产提供抵押担保，担保最高额 度为 800 万元。 二、被担保人基本情况 公司名称：杭州创化 ...

公司拟为杭州创化与福建片仔癀化妆品股份有限公司（"片仔癀"）签订的 2025 年度片仔癀化妆品经销合同书所约定的账期以自有房产提供抵押担保，担保最高额 度为 800 万元。抵押物为公司名下位于山西省太原市滨河西路 51 号 3 幢 1-2 层 0201 号非住宅房地产（不动产权证号为：晋（2024）太原市不动产权第 0010929 号）， 截至评估基准日 2024 年 12 月 31 日，上述房产市场价值经市场法评估，评估价值 1131.00 万元。杭州创化及其股东昆汀科技为公司的上述抵押担保提供反担保。 被担保人名称：杭州创化电子商务有限公司（"杭州创化"），为杭州昆汀数字科技 有限公司（"昆汀科技"）全资子公司，公司通过昆汀科技间接持有杭州创化 58% 的股份 本次抵押担保金额及已实际为其提供的担保余额：本次抵押担保最高额限额为 800 万元人民币。本次新增抵押担保后，公司为杭州创化提供的担保总额为 800 万元（即 本次担保）。 本次担保是否有反担保：是 对外担保逾期的累计数量：无 证券代码：600539 证券简称：狮头股份 公告编号：临 2025-038 狮头科技发展股份有限公司 关于为控股子公司提供 ...

证券代码：600539 证券简称：狮头股份 公告编号：临 2025-037 狮头科技发展股份有限公司 第九届董事会第二十一次会议决议公告 表决结果：同意 8 票，反对 0 票，弃权 0 票，表决通过。 在提交本次董事会审议前，该议案已经公司董事会审计委员会审议通过。 具体内容请查阅同日披露于上海证券交易所网站（www.sse.com.cn）的《关 于为控股子公司提供抵押担保的公告》（临 2025-038） 特此公告。 狮头科技发展股份有限公司董事会 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 狮头科技发展股份有限公司（以下简称"公司"或"狮头股份"）第九届董事会 于 2025 年 6 月 17 日以现场与通讯表决相结合的方式在公司会议室召开了第二十 一次会议，本次会议应参与表决董事 9 人，实际参与表决董事 8 人，董事孙素宾 先生因工作原因未能出席本次会议。公司监事及高级管理人员列席了本次会议。 本次会议符合《公司法》和《公司章程》的规定。会议审议并通过了如下议案： 一、审议通过了《关于为控股子公司提供抵押担保的议 ...

证券代码：600539 证券简称：狮头股份 公告编号：临 2025-036 狮头科技发展股份有限公司 关于发行股份及支付现金购买资产并募集配套资金 暨关联交易事项的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次交易标的资产的审计、评估工作尚未完成，交易价格尚未确定。本 次交易方案尚需经公司董事会及股东大会批准、上交所审核、中国证监会同意注 册及相关法律法规所要求的其他可能涉及的批准或核准（如需）。上述批准、审 核通过和同意注册均为本次交易的前提条件。本次交易能否取得上述批准、审核 通过或同意注册，以及最终取得的时间均存在不确定性。 本次交易方案由发行股份及支付现金购买资产和募集配套资金两部分组 成。本次发行股份及支付现金购买资产与募集配套资金的成功实施互为前提，其 中任何一项未获得所需的批准或其他原因导致无法付诸实施，则前述两项均不实 施。截至本公告日，募集配套资金认购方尚未提供资金证明等相关材料，若未来 募集配套资金认购方未能及时、足额认缴配套融资，或因其他原因导致本次募集 配套资金未能成 ...

Market Overview - The three major stock indices collectively declined, with the Shanghai Composite Index closing at 3339.93 points, down 0.02%, the Shenzhen Component Index at 10003.27 points, down 0.26%, and the ChiNext Index at 1985.38 points, down 0.31% [1]. Sector Performance - Strong sectors included medical waste treatment (+2.66%), combustible ice (+2.50%), beverage manufacturing (+2.30%), controllable nuclear fusion (+2.02%), and textile and apparel (+1.48%) [4]. - The internet e-commerce sector led the decline, with a drop of -2.01%, followed by medical services at -1.81% [4]. Individual Stock Highlights - In the medical waste treatment sector, notable performers included Yuhua Tian and Boschke, both hitting the 20% daily limit up, while Qiaoyin Co. also reached the limit up [4]. - The combustible ice sector saw ShenKai Co. hitting the limit up, with potential gains for QianNeng HengXin (+8%) and other companies like HaiMo Technology and Sinopec following suit [4]. Fund Flow Analysis - Major funds saw net inflows in sectors such as machinery, power equipment, and communications, while experiencing net outflows in banking, media, and public utilities [5]. - Specific stocks with significant net inflows included XueRen Co. (5.06 billion), GongXiao DaJi (3.37 billion), and GuoFang Group (3.36 billion) [6]. - Conversely, companies like BYD, Great Wall Motors, and Seres faced substantial sell-offs, with net outflows of 8.33 billion, 7.51 billion, and 6.21 billion respectively [7]. Institutional Insights - Dongfang Securities noted that liquidity disturbances are expected to continue, with long-term bond yields likely to remain high, indicating a tight overall market liquidity [8]. - The report emphasized that sectors with better performance visibility, such as consumption and pharmaceuticals, may offer relatively better short-term elasticity [8]. - Galaxy Securities advised caution in chasing high valuations in the fast-rotating new consumption sector [9]. - Guotai Haitong expressed a mid-term positive outlook on beverage manufacturing but recommended against chasing high prices in the short term [10].

Group 1 - The A-share internet e-commerce sector experienced a sharp rise, with Xinghui Co., Ltd. increasing by over 10% [1] - Other companies such as Saiwei Times, Yiwan Yichuang, Shitou Co., Ltd., Nanji E-commerce, and Santai Co., Ltd. also saw significant gains [1]

Core Viewpoint - The pet stock sector has experienced significant growth, with a year-to-date increase of 36%, driven by the recent "618" sales event [1][4]. Group 1: Market Performance - Leading companies in the pet sector, such as Tianyuan Pet and Zhongchong Co., have seen stock increases of approximately 80% and over 70% respectively, with Zhongchong Co. rising from 17 yuan to 63.8 yuan, a 245% increase since July of the previous year [4]. - The "pet economy index" has shown no declines among its constituent stocks this year, indicating a strong upward trend [4]. - During the initial hours of the "618" sales event, 653 pet brands on Tmall saw their sales double year-on-year, with significant increases in sales for brands like Xianlang and Dazhongai, both experiencing growth of nearly 200% [4]. Group 2: Investment Trends - Public funds are primarily focusing on leading stocks in the pet sector, with a notable lack of interest in smaller-cap stocks despite their impressive performance [2][5]. - For instance, the leading stock, Guibao Pet, had a public fund holding ratio of 7.63% as of the end of Q1, while Zhongchong Co. was included as a major holding by 71 funds [5]. - Smaller companies like Tianyuan Pet, which specializes in pet home products, have not attracted significant public fund investments, although recent investor interest has been noted [5]. Group 3: Future Growth Potential - The pet industry is projected to continue its growth, with estimates suggesting that the urban pet consumption market will exceed 404.2 billion yuan by 2027, reflecting a compound annual growth rate of 12.6% [4]. - The pet food market is expected to capture nearly half of the total pet economy, indicating substantial growth potential [6]. - The aging pet population is anticipated to drive demand in the pet medical sector, which is currently underrepresented in the public market [6]. Group 4: Competitive Landscape - The competitive landscape within the pet industry is evolving, with a trend towards increased market concentration among leading brands, as smaller companies face challenges such as funding issues and layoffs [8]. - The market is witnessing a shift from a pyramid structure to a spindle structure, where leading domestic brands are expected to gain market share from imported brands while upgrading their product offerings [9]. - The demand for pet medical services is also expected to grow due to the aging pet population, further contributing to market concentration among leading providers [9].

Group 1 - The company will hold a performance briefing for the fiscal year 2024 and the first quarter of 2025 on May 30, 2025, from 15:00 to 16:00 [1][2] - The briefing will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [2][3] - Investors can submit questions for the briefing from May 23, 2025, to May 29, 2025, by logging into the Roadshow Center or via the company's email [3] Group 2 - Key participants in the briefing will include the company's president, financial officer, and independent directors [2] - After the briefing, investors can access the main content and details of the event through the Shanghai Stock Exchange Roadshow Center [3]